THE EFFECTS OF UPADACITINIB ON ULCERATIVE COLITIS SYMPTOM RESOLUTION AND FATIGUE NORMALIZATION IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 3 U-ACHIEVE AND U-ACCOMPLISH RESULTS

被引：0
|
作者：
D'Haens, Geert
Tran, Jacinda N.
Danese, Silvio
Rubin, David T.
Aoyama, Nobuo
Lugering, Andreas
Klaff, Justin
Xuan, Si
Ilo, Dapo
Gonzalez, Yuri Sanchez
Panes, Julian
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1737
引用
收藏
页码：S1102 / S1103
页数：2
相关论文
共 50 条
  • [21] Comparison of three histologic indices in ulcerative colitis: Evaluation from the Phase 2 study of upadacitinib (U-ACHIEVE)
    Jairath, V.
    Lee, W. J.
    Zhou, W.
    Heap, G.
    Butler, J.
    Shields, A. L.
    Ollis, S.
    Harpaz, N.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S210 - S211
  • [22] Rapidity of Symptom Control with Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Two Randomized Phase 3 Studies
    Loftus, Edward V.
    Takeuchi, Ken
    Gao, Xiang
    Panaccione, Remo
    Danese, Silvio
    Ilo, Dapo
    Finney-Hayward, Tricia
    Phillips, Charles
    Yao, Xuan
    Vermeire, Severine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S359 - S359
  • [23] CORRELATION OF HISTOLOGICAL ASSESSMENT OF MUCOSAL HEALING WITH LONG-TERM CLINICAL AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH UPADACITINIB: RESULTS FROM PHASE 3 U-ACHIEVE MAINTENANCE TRIAL
    Parke, Gareth
    Ungaro, Ryan C.
    Danese, Silvio
    Abreu, Maria T.
    Arenson, Ethan
    Zhou, Wen
    Ilo, Dapo
    Laroux, Stephen
    Deng, Huiwen
    Gonzalez, Yuri Sanchez
    Peyrin-Biroulet, Laurent
    GASTROENTEROLOGY, 2022, 162 (07) : S970 - S970
  • [24] Correlation of histological assessment of mucosal healing with long-term clinical and patient-reported outcomes in patients with moderately to severely active ulcerative colitis treated with upadacitinib: results from the Phase 3 U-ACHIEVE maintenance trial
    Parkes, G.
    Ungaro, R.
    Danese, S.
    Abreu, M.
    Arenson, E.
    Zhou, W.
    Ilo, D.
    Laroux, F. S.
    Deng, H.
    Gonzalez, Y. Sanchez
    Peyrin-Biroulet, L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I476 - I477
  • [25] Correlation of histological assessment of mucosal healing with long-term clinical and patient-reported outcomes in patients with moderately to severely active ulcerative colitis treated with upadacitinib: Results from the Phase 3 U-ACHIEVE maintenance trial
    Parkes, G.
    Ungaro, R.
    Danese, S.
    Abreu, M.
    Arenson, E.
    Zhou, W.
    Ilo, D.
    Laroux, S.
    Deng, H.
    Gonzalez, Y. S.
    Peyrin-Biroulet, L.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 157 - 157
  • [26] Correlation of histological assessment of mucosal healing with long-term clinical and patient-reported outcomes in patients with moderately to severely active ulcerative colitis treated with upadacitinib: results from the Phase 3 U-ACHIEVE maintenance trial
    Parkes, G.
    Ungaro, R.
    Danese, S.
    Abreu, M.
    Arenson, E.
    Zhou, W.
    Ilo, D.
    Laroux, F. S.
    Deng, H.
    Gonzalez, Y. Sanchez
    Peyrin-Biroulet, L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I476 - I477
  • [27] Benefit-Risk Assessment of Upadacitinib Treatment in Patients With Moderately to Severely Active Ulcerative Colitis
    Panaccione, Remo
    Blumenstein, Irina
    Irving, Peter
    Vladea, Ramona
    Ilo, Dapo
    Zhou, Wen
    Levy, Gweneth
    Yao, Xuan
    Dotan, Iris
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S553 - S554
  • [28] Cost-Effectiveness Analysis of Upadacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in Greece
    Tzanetakos, Charalampos
    Psarra, Marina
    Kotsis, Ilias
    Gourzoulidis, George
    VALUE IN HEALTH REGIONAL ISSUES, 2025, 46
  • [29] COST-EFFECTIVENESS ANALYSIS OF UPADACITINIB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN GREECE
    Tzanetakos, C.
    Psarra, M.
    Kotsis, I
    Gourzoulidis, G.
    VALUE IN HEALTH, 2023, 26 (12) : S144 - S144
  • [30] EFFICACY OF UPADACITINIB AS AN INDUCTION THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS, WITH OR WITHOUT PREVIOUS TREATMENT FAILURE OF BIOLOGIC THERAPY: DATA FROM THE DOSE-RANGING PHASE 2B STUDY U-ACHIEVE
    Panaccione, Remo
    D'Haens, Geert R.
    Sandborn, William J.
    Ghosh, Subrata
    Schreiber, Stefan
    Tanida, Satoshi
    Zhou, Wen
    Cataldi, Fabio
    Pugatch, David
    Huang, Bidan
    Xie, Wangang
    Higgins, Peter D.
    GASTROENTEROLOGY, 2019, 156 (06) : S170 - S170
12345